Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Harvard Bioscience revenue
Harvard Bioscience's revenue is $94.1 million.
What is Harvard Bioscience's revenue?
- Harvard Bioscience's revenue growth from 2000 to 2024 is 207.88%.
- Harvard Bioscience has 428 employees, and the revenue per employee ratio is $219,941.
- Harvard Bioscience's peak quarterly revenue was $33.9M in 2018(q4).
- Harvard Bioscience peak revenue was $120.8M in 2018.
- Harvard Bioscience annual revenue for 2023 was 112.3M, -0.96% growth from 2022.
- Harvard Bioscience annual revenue for 2024 was 94.1M, -16.14% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Harvard Bioscience historical revenue
Harvard Bioscience's peak revenue was $120.8M in 2018. The peak quarterly revenue was $33.9M in 2018(q4).
Harvard Bioscience's revenue increased from $30.6b in 2000 to $94.1M currently. That's a 207.88% change in annual revenue.
Harvard Bioscience annual revenue
Harvard Bioscience annual revenue over time
| Fiscal year / year | Harvard Bioscience revenue |
|---|---|
| 2009 | $85.8M |
| 2010 | $108.2M |
| 2011 | $108.9M |
| 2012 | $111.2M |
| 2013 | $105.2M |
| 2014 | $108.7M |
| 2015 | $108.7M |
| 2016 | $104.5M |
| 2017 | $77.4M |
| 2018 | $120.8M |
| 2019 | $116.2M |
| 2020 | $102.1M |
| 2021 | $118.9M |
| 2022 | $113.3M |
| 2023 | $112.3M |
| 2024 | $94.1M |
How accurately did Harvard Bioscience's revenue projections match actual performance?
Harvard Bioscience annual growth
Harvard Bioscience saw the greatest revenue growth in 2018, when revenue increased by 56.02%.
Harvard Bioscience had the lowest revenue growth in 2002, when revenue changed by -99.86%.
Harvard Bioscience annual growth rate over time
| Year | Harvard Bioscience growth |
|---|---|
| 2009 | -3%↓ |
| 2010 | 26%↑ |
| 2011 | 1%↑ |
| 2012 | 2%↑ |
| 2013 | -5%↓ |
| 2014 | 3%↑ |
| 2015 | 0%↑ |
| 2016 | -4%↓ |
| 2017 | -26%↓ |
| 2018 | 56%↑ |
| 2019 | -4%↓ |
| 2020 | -12%↓ |
| 2021 | 16%↑ |
| 2022 | -5%↓ |
| 2023 | -1%↓ |
| 2024 | -16%↓ |
Harvard Bioscience quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Harvard Bioscience quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $19.1M | $18.0M | $21.0M | $27.7M |
| 2010 | $26.3M | $25.9M | $26.5M | $29.5M |
| 2011 | $26.3M | $27.1M | $26.4M | $29.0M |
| 2012 | $28.3M | $28.5M | $26.1M | $28.2M |
| 2013 | $26.1M | $26.1M | $25.1M | $27.9M |
| 2014 | $25.9M | $27.0M | $25.4M | $30.4M |
| 2015 | $25.8M | $28.8M | $25.7M | $28.4M |
| 2016 | $27.0M | $26.1M | $25.0M | $26.4M |
| 2017 | $18.1M | $19.0M | $18.7M | $21.6M |
| 2018 | $26.8M | $31.5M | $28.6M | $33.9M |
| 2019 | $28.2M | $29.6M | $27.4M | $31.0M |
| 2020 | $23.8M | $23.3M | $24.0M | $31.0M |
| 2021 | $27.0M | $29.2M | $29.7M | $33.1M |
| 2022 | $28.8M | $29.2M | $26.9M | $28.4M |
| 2023 | $30.0M | $28.8M | $25.4M | $28.2M |
| 2024 | $24.5M | $23.1M | $22.0M | $24.6M |
Harvard Bioscience jobs nearby
Do you work at Harvard Bioscience?
Did Harvard Bioscience meet its revenue projections?
Harvard Bioscience financial information
| CEO | James W. Green |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 428 |
| Date Founded | 1901 |
| Headquarters | Holliston, Massachusetts |
| Number of Locations | 4 |
| Revenue | $94.1M |
| Net Income | -$9,516,000 |
| Gross Proft | $54.8M (2024) |
| EBITDA | ($3.2M) (2024) |
| PE Ratio | -9.11 |
| Tax Rate | -0.1% |
| Market Capitalization | $113.0M |
| Total Assets | $145,360,000 |
| Ticker | HBIO |
Harvard Bioscience jobs you might like
Harvard Bioscience investors
| Investors | Security type |
|---|---|
| New England Partners | |
| Ascent Venture Partners | |
| First New England Capital |
Harvard Bioscience competitors
Harvard Bioscience's top competitor, Merck, earned an annual revenue of $64.2B.
Harvard Bioscience's smallest competitor is Visi Global with revenue of $31.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| The Dow Chemical Company | $67,440 | $43.0B | 54,000 | 113 |
| Bayer | $89,204 | $17.0B | 20,735 | 1,542 |
| Merck | $90,328 | $64.2B | 74,000 | 2,468 |
| Mine Safety Appliances | $58,485 | $1.8B | 5,000 | 22 |
| Molecular Devices | $85,783 | $150.0M | 631 | - |
| SCIEX | $52,457 | $44.4M | 100 | - |
| Biodex | $57,657 | $28.9M | 200 | 9 |
| Spacelabs Medical Inc | $48,941 | $24.0M | 50 | - |
| HydraFacial | $65,680 | $260.1M | 578 | 11 |
| PerkinElmer | $85,448 | $2.8B | 14,000 | 135 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Harvard Bioscience highest paying jobs
Zippia gives an in-depth look into the details of Harvard Bioscience, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Harvard Bioscience. The employee data is based on information from people who have self-reported their past or current employments at Harvard Bioscience. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Harvard Bioscience. The data presented on this page does not represent the view of Harvard Bioscience and its employees or that of Zippia.
Harvard Bioscience may also be known as or be related to Harvard Apparatus, Inc., Harvard Bioscience, Harvard Bioscience Inc and Harvard Bioscience, Inc.